Vermillion Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Austin, TX USA
Total Funding:$88M
Industry:Biotech
Founded:1993
Lead Investor(s):Canaccord Genuity

Industry Ranking

Estimated Revenue & Financials

  • Vermillion's estimated annual revenue is currently $2.9M per year.
  • Vermillion received $10.7M in venture funding in February 2017.
  • Vermillion's estimated revenue per employee is $62,340
  • Vermillion's total funding is $88M.

Employee Data

  • Vermillion has 47 Employees.
  • Vermillion grew their employee count by 42% last year.
  • Vermillion currently has 8 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
Food Safety Net...
$58.9M3805%N/A-N/A
Bellicum Pharma...
$1.1M154-11%N/A-N/A
AccessDx Lab
$7M45309%N/A-N/A
G-CON Manufactu...
$11.2M7233%N/A-N/A
BioNews Service...
$11.3M7311%N/A-N/A
Santa Cruz Biot...
$31.9M206N/AN/A-N/A
Luminex Corpora...
$176.4M113810%N/A-N/A
Asuragen
N/A174N/AN/A-N/A
Family Tree DNA
$7.3M4718%N/A-N/A
XBiotech USA
$13.8M8913%N/A-N/A
Missing a competitor? Contribute!?
Submit

Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion, along with its prestigious scientific collaborators, discovers, develops, and delivers innovative diagnostic and technology tools that help women with serious diseases. The company's initial in vitro diagnostic test, OVA1®, was the first FDA-cleared, protein-based In Vitro Diagnostic Multivariate Index Assay, and represented a new class of software-based liquid biopsy in vitro diagnostics. In March 2016 Vermillion received FDA clearance for Overa, a second generation OVA1 test with significantly improved specificity and ease of use.

keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals

47

Number of Employees

$2.9M

Revenue (est)

8

Current Jobs

42%

Employee Growth %

$88M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Vermillion News

09/08/2019 - Vermillion halted ferry services in violation of agreement'

Ministry of Transport and Civil Aviation declared Sunday that Vermillion Maldives halted ferry services in the atolls of Meemu, Faafu and Dhaalu ...

09/06/2019 - Happiness Was Wet Puppies In Vermillion Monday Evening

For a couple hours Monday evening in Vermillion, happiness wasn't a ... the refreshing waters of the Prentis Plunge of Vermillion in that facility's ...

09/06/2019 - Clay County Sheriff's Office

1:05 PM -- A deputy responded to a report of a motorcycle abandoned near Vermillion. The motorcycle was determined to be one that was ...

Vermillion Funding

DateAmountRoundLead InvestorsReference
2003-08-20$25.0MNotesArticle
2010-01-08$43.0MUndisclosedArticle
2011-02-16$21.8MUndisclosedRoth Capital PartnersArticle
2013-05-10$31.5MUndisclosedOracle Investment ManagementArticle
2013-12-20$17.6MUndisclosedArticle
2014-12-24$10.5MUndisclosedOracle Investment ManagementArticle
2014-12-26$10.5MUndisclosedOracle Investment ManagementArticle
2015-07-14$UndisclosedUndisclosedCanaccord GenuityArticle
2017-02-15$10.7MUndisclosedArticle

Vermillion Executive Hires

DateNameTitleReference
2004-03-09William SullivanVP/Diagnostic OperationsArticle
2004-07-15Eric FungVP Clinical and Medical AffairsArticle
2005-03-15James P. MerryweatherEVP Corp DevelopmentArticle
2006-06-20Eric T. FungChf Scientific OffArticle
2006-11-07Debra A. YoungVP/CFOArticle
2007-05-16Steve LundySVP Sales/MarketingArticle
2010-02-03Gail S. PageCEOArticle
2010-04-20Sandra A. GardinerVP/CFOArticle
2010-09-24Jeffrey M. SalzmanDir Corporate ReimbursementArticle
2010-10-04Ashish KohliVP Corporate StrategyArticle
2011-09-27Donald MunroeChief Scientific Officer/VP R&DArticle
2012-11-28Bruce A. HuebnerInterim CEOArticle
2013-03-14Thomas McLainPresident/CEOArticle
2013-03-20Bruce A. HuebnerChairmanArticle
2013-12-16James T. LaFranceChairmanArticle
2013-12-18Marian E. SaccoSVP Sales/Marketing/Chief Commercial OfficerArticle
2014-04-24James LaFranceCEO/President/ChairmanArticle
2014-08-15David JansenVP MarketingArticle
2014-08-22Holly B. BauzonVP Sales/Managed MarketsArticle
2014-10-28Valerie PalmieriChief Operating OfficerArticle
2014-12-17Valerie PalmieriPresident/CEOArticle
2015-01-13Laura MillerSVP Sales/Customer ExperienceArticle
2016-11-15Marra FrancisChief Medical OfficerArticle

Vermillion New Location/Offices

DateLocationReference
2010-07-26Austin, TXArticle

Vermillion Acquisitions

DateCompany NameAmountNotesReference
2004-10-29Pall CorporationArticle
2011-12-20Correlogic Systems Assets Deal -CompleteArticle